Evidence map›Paper›PMID 32292194›Full record

ArticleAmerican journal of pharmaceutical education2020

Appropriateness of Term Limits for Administrative Appointments in Pharmacy Programs.

Daniel R Malcom, Karen Farris, David J Feola, Peter M Gannett, Anandi V Law, Katherine S O'Neal, Francine D Salinitri, Katherine Tromp, Annesha White

Abstract read
In one paragraph

Article in American journal of pharmaceutical education, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Term Limits in Academic Public Health Administration.Public health reports (Washington, D.C. : 1974)
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Daniel R MalcomSullivan University College of Pharmacy and Health Sciences, Louisville, Kentucky.
Karen FarrisUniversity of Michigan College of Pharmacy, Ann Arbor, Michigan.
David J FeolaUniversity of Kentucky College of Pharmacy, Lexington, Kentucky.
Peter M GannettNova Southeastern University College of Pharmacy, Fort Lauderdale, Florida.
Anandi V LawWestern University of Health Sciences College of Pharmacy, Pomona, California.
Katherine S O'NealUniversity of Oklahoma Health Sciences Center College of Pharmacy, Oklahoma City, Oklahoma.
Francine D SalinitriWayne State University, Eugene Applebaum College of Pharmacy and Health Sciences, Detroit, Michigan.
Katherine TrompLake Erie College of Osteopathic Medicine School of Pharmacy, Bradenton, Florida.
Annesha WhiteUniversity of North Texas Health Science Center College of Pharmacy, Fort Worth, Texas.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The appropriateness of term limits for administrative appointments is a subject of much discussion, not just within pharmacy programs, but in organizations of all types. The prospect of term limits for involves a wide variety of important organizational issues, including succession planning, institutional memory, strategic decision-making, and concepts regarding leadership styles overall. This paper examines both sides of the debate regarding the appropriateness of term limits for administrative appointments. Arguments supporting term limits include the ability for strategic changes in the diversity of leaders as well as a more focused effort on continuous quality improvement. The arguments against term limits focus around the need for stability and the time involved in the development of effective leaders.

Indexed as

Education, PharmacyHumansLeadershipPharmaceutical ServicesPharmacyacademiaadministrationleadershipsuccession planningterm limits

Identifiers

PMID32292194
PMCPMC7055408

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.